Breast CancerClinical TopicsImmunotherapyLung CancerNewsOncologyOncology Resource Center

New findings from the American Cancer Society on reduced cancer mortality rates

Share
By: Lydia L. Kim, Digital Content Editor

Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in the US. Additionally, between 2016 to 2017, there was a 2.2% drop, which is the largest drop within a single year that was ever recorded.

The report calls out some key statistics of major cancer types:

  1. Between 1990 and 2017, rates of lung cancer deaths in men dropped by 5% per year, and for women, 4% per year.
  2. Between 1989 and 2017, the rates of breast cancer deaths in women dropped by 40%
  3. Between 1993 and 2017, the rates of prostate cancer deaths in men dropped by 52%
  4. Between 1980 and 2017, the rates of colorectal cancer deaths in men dropped by 53% in men, and 57% in women

The American Cancer Society’s report describes one of the largest factors of the reduction of cancer mortality rates was due to the introduction of several immunotherapies and targeted therapies.

Please read the entire report from the American Cancer Society here.

Source:
https://www.cancer.org/latest-news/facts-and-figures-2020.html

*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?

More News